CRISPR Therapeutics gets a snapshot of off-the-shelf CAR-T success in B-cell malignancies — marred by the death of a patient
Just days after scientific founder Emmanuelle Charpentier shared the Nobel prize for her work on CRISPR/Cas9, CRISPR Therapeutics $CRSP is showing off a snapshot …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
